CY-09
CY-09 (NLRP3 inhibitor CY-09) is a selective and direct NLRP3 inhibitor, binds to the ATP-binding motif of NLRP3 NACHT domain and inhibits NLRP3 ATPase activity; suppresses NLRP3 inflammasome assembly and activation, shows remarkable therapeutic effects on mouse models of cryopyrin-associated autoinflammatory syndrome (CAPS) and type 2 diabetes.
Product Specifications
CAS Number
1073612-91-5
Product Name Alternative
NLRP3 inhibitor CY-09
Purity
>98% (HPLC)
Solubility
DMSO: 77 mg/mL (181.8 mM) (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
O=C (O) C1=CC=C (/C=C (SC (N2CC3=CC=CC (C (F) (F) F) =C3) =S) \C2=O) C=C1
Molecular Formula
C19H12F3NO3S2
Molecular Weight
423.424
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Benzoic acid, 4-[[4-oxo-2-thioxo-3-[[3- (trifluoromethyl) phenyl]methyl]-5-thiazolidinylidene]methyl]-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
LSM14A, CT (LSM14A, C19orf13, FAM61A, RAP55, RAP55A, Protein LSM14 homolog A, Protein FAM61A, Protein SCD6 homolog, Putative alpha-synuclein-binding protein, RNA-associated protein 55A) (AP) discontinued
Nuclear pore complex protein Nup153 (NUP153) Rat ELISA Kit